Trial Profile
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU): Impact on Antimicrobial Resistance, Superinfections, Length of ICU Stay and Hospitalization, and Mortality
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 04 Jul 2017
Price :
$35
*
At a glance
- Drugs Meropenem (Primary)
- Indications Bacterial infections
- Focus Therapeutic Use
- 28 Mar 2013 Planned End Date changed from 1 May 2007 to 1 Feb 2007 as reported by ClinicalTrials.gov.
- 28 Mar 2013 Planned End Date changed from 1 May 2007 to 1 Feb 2007 as reported by ClinicalTrials.gov.
- 02 Mar 2007 Status changed from recruiting to discontinued.